Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Depreciation & Amortization (CF) (2024 - 2025)

Hinge Health's Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 10.47% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $4.2 million, up 49.28%, while the annual FY2025 figure was $5.1 million, 13.73% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $1.2 million at Hinge Health, down from $1.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.4 million in Q3 2024 and bottomed at $300000.0 in Q2 2025.